Eisler Capital Management’s Amedisys AMED Stock Holding History

Eisler Capital Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-52,762	Closed	-$5.19M	–	829
2025 Q2	$5.19M	Buy	+52,762	New	+$4.99M	0.03%	386
2025 Q1	–	Sell	-40,000	Closed	-$3.63M	–	917
2024 Q4	$3.63M	Buy	+40,000	New	+$3.67M	0.02%	490

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Eisler Capital Management's AMED Position: Q3 2025 in Review

Eisler Capital Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 52,762 shares — an estimated $5.19M sold.

Eisler Capital Management first reported a position in AMED in Q4 2024 and held it in 2 quarters. The position peaked at $5.19M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

Eisler Capital Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
Eisler Capital Management sold 52,762 Amedisys shares in Q3 2025, an estimated $5.19M.
Eisler Capital Management first reported a position in Amedisys in Q4 2024 and held it in 2 quarters.
Eisler Capital Management's Amedisys position peaked at $5.19M in Q2 2025.
4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Eisler Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.